|
Banerjee A., Marín F., Lip G.Y.H. The improved but unfinished business of stroke risk stratification in atrial fibrillation. Revista Espanola de Cardiologia. August 2011. 64:639-641. 10.1016/j.recesp.2011.04.005
AÑO: 2011; IF: 2.53
|
|
Orenes-Piñero E, Hernández-Romero D, Jover E, de la Morena G, Valdés M, Marín F. An insight of novel pharmacological therapies in hypertrophic cardiomyopathy. Med Chem. 2011 Jul;7(4):275-85. Review. PubMed PMID: 21568880.
AÑO: 2011; IF: 1.496
|
|
Lip G.Y.H., Andreotti F., Fauchier L., Huber K., Hylek E., Knight E., Lane D., Levi M., Marin F., Palareti G., Kirchhof P. Bleeding risk assessment and management in atrial fibrillation patients: Executive summary<sup>#</sup> of a position document from the european heart rhythm association [EHRA], endorsed by the european society of cardiology [ESC] working group on thrombosis. Thrombosis and Haemostasis. 2011. 106:997-1011. 10.1160/TH11-10-0690
AÑO: 2011; IF: 5.044
|
|
Montoro-Garca S., Marn F., Lip G.Y.H. Thrombogenesis in lone atrial fibrillation: A role for soluble P-selectin?. Europace. January 2011. 13:3-4. 10.1093/europace/euq376
AÑO: 2011; IF: 1.98
|
|
Muñoz-Esparza C, Jover E, Hernández-Romero D, Saura D, Valdés M, Lip GY, Marín F. Interactions between clopidogrel and proton pump inhibitors: a review of evidence. Curr Med Chem. 2011;18(16):2386-400. Review. PubMed PMID: 21568918.
AÑO: 2011; IF: 4.859
|